RDY:NYSE
Dr Reddy's Laboratories Ltd
US$Â 13.07
arrow_upward
+1.32%(+0.17) Siku 1
US$Â 13.07
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 16 Okt, 16:00:07 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya RDY...
Fungua
US$Â 13.00
Juu
US$Â 13.07
Chini
US$Â 12.94
Mtaji wa soko
10.81B
Wastani wa kiasi cha mauzo
3.19M
Kiasi cha mauzo ya hisa
2.79M
Gawio
0.64%
Mgawo wa faida wa kila robo mwaka
US$Â 0.02
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.34
Juu kwa wiki 52
US$Â 15.67
Chini kwa wiki 52
US$Â 11.36
EPS
US$Â 0.42
Beta
0.30
Hisa za wawekezaji
834.64M
Idadi ya wafanyakazi
elfu 28
Fungua
US$Â 13.00
Juu
US$Â 13.07
Chini
US$Â 12.94
Mtaji wa soko
10.81B
Wastani wa kiasi cha mauzo
3.19M
Kiasi cha mauzo ya hisa
2.79M
Gawio
0.64%
Mgawo wa faida wa kila robo mwaka
US$Â 0.02
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.34
Juu kwa wiki 52
US$Â 15.67
Chini kwa wiki 52
US$Â 11.36
EPS
US$Â 0.42
Beta
0.30
Hisa za wawekezaji
834.64M
Idadi ya wafanyakazi
elfu 28
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
siku 3 zilizopita
Dr Reddy reports three FDA observations: what it means for Dr Reddy stock
MarketBeat
·
siku 3 zilizopita
Dr. Reddy's Laboratories (NYSE:RDY) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?
Wasifu
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Kuhusu Dr Reddy's Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)Erez Israeli
Wafanyakazielfu 27.5
Lilianzishwa1984
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutidrreddys.com